Tazicef

Ceftazidime (third-generation cephalosporin with Pseudomonas coverage) for serious gram-negative infections. Third-generation cephalosporin (ceftazidime). Mechanism: binds PBPs — particularly PBP3 → inhibits cell wall synthesis (bactericidal). Extended spectrum: excellent gram-negative coverage including Pseudomonas aeruginosa; good stability against many beta-lactamases. IV/IM or ophthalmic use. Key information Ceftazidime — see ceftazidime entry. Reconstitute; refrigerate; use within 24 hours.

IV or IM: dilute in compatible solution; infuse over 30 min. Deep IM for intramuscular route. Store refrigerated (2–8°C); do not freeze. (reconstituted — check label for stability period). If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

GI: diarrhea, nausea. Hypersensitivity (beta-lactam class). Phlebitis (IV). CNS: seizures (high doses, renal impairment). Superinfection.

For animals See ceftazidime. Reduce dose or extend interval in renal impairment. Avoid in beta-lactam-hypersensitive patients. For people handling this medication Wear gloves when handling. Wash hands thoroughly with soap and water after handling. Cephalosporin injectable — inform doctor if beta-lactam allergic. Wear gloves.

Contact your veterinarian. Ceftazidime overdose may cause seizures. Supportive care required.